The use of intravenous palivizumab for treatment of persistent RSV infection in children with leukemia

Pediatrics

Volumn 130, Issue 6, 2012, Pages

  Santos, Roberto P ^a   Chao, Jeffery ^a   Nepo, Anne G ^a   Butt, Shafiq ^a   Stellrecht, Kathleen A ^a   Pearce, Jennifer M ^a   Lepow, Martha L ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

Children; Intravenous palivizumab; Leukemia; RSV

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PALIVIZUMAB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHILD; DOWN SYNDROME; DRUG TOLERABILITY; FEMALE; FEVER; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; LOWER RESPIRATORY TRACT INFECTION; MALE; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; RESPIRATORY DISTRESS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SURVIVAL RATE; TACHYCARDIA; THORAX RADIOGRAPHY;

EID: 84870571817     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1768     Document Type: Article

References (22)

1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(suppl 5):S127-S132 (Pubitemid 37456910)
2. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440-1446 (Pubitemid 29493797)
3. Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol. 2011;46(4):324-347
4. Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J. 2003;22(suppl 2):S33-S37; discussion S37-S39
5. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007;26(12):1089-1093 (Pubitemid 350190938)
6. de Fontbrune FS, Robin M, Porcher R, et al. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2007;45(8):1019-1024 (Pubitemid 47580353)
7. Gen-Probe, Inc. Prodesse Pro Flu+. Novato, CA: Biosearch Technologies, Inc; 2010:1-29
8. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest. 1991;88(3):1026-1033
9. Stensballe LG, Ravn H, Kristensen K, et al. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol. 2009;123(2):398-403
10. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56-e93
11. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006;85(5):278-287 (Pubitemid 44401460)
12. Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunological features of Down's syndrome: a review. J Intellect Disabil Res. 1993;37(pt 6):543-551 (Pubitemid 23362851)
13. Bloemers BL, Broers CJ, Bont L, Weijerman ME, Gemke RJ, van Furth AM. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect. 2010;12(11):799-808
14. Bloemers BL, van Furth AM, Weijerman ME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis - a prospective birth-cohort study. Pediatrics. 2007;120(4). Available at: www.pediatrics.org/ cgi/content/full/120/4/e1076
15. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children with bronchiolitis. Pediatrics. 1998;101(4 pt 1):617-619 (Pubitemid 28180143)
16. Krilov LR. Respiratory syncytial virus (RSV) infection. In: Medscape Reference; 2010. Available at: http://emedicine.medscape.com/article/971488- overview. Accessed June 7, 2011
17. Paget SP, Andresen DN, Kesson AM, Egan JR. Comparison of human metapneumovirus and respiratory syncytial virus in children admitted to a paediatric intensive care unit. J Paediatr Child Health. 2011;47(10):737-741
18. Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, Hart CA. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis. 2003;9(3):372-375 (Pubitemid 36330880)
19. Liao RS, Tomalty LL, Majury A, Zoutman DE. Comparison of viral isolation and multiplex real-time reverse transcription-PCR for confirmation of respiratory syncytial virus and influenza virus detection by antigen immunoassays. J Clin Microbiol. 2009;47(3):527-532
20. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis. 2008;46(3):402-412 (Pubitemid 351263523)
21. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011;117(10):2755-2763
22. Lagos R, DeVincenzo JP, Muñoz A, et al. Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children. Pediatr Infect Dis J. 2009;28(9):835-837